Thromb Haemost 1995; 74(05): 1335-1339
DOI: 10.1055/s-0038-1649936
Original Article
Vessel Wall
Schattauer GmbH Stuttgart

Production of Platelet-Activating Factor by Porcine Brain Microvascular Endothelial Cells in Culture

Kei Satoh
The Department of Pathological Physiology, Institute of Neurological Diseases, Hirosaki University School of Medicine, Hirosaki, Japan
,
Hidemi Yoshida
The Department of Pathological Physiology, Institute of Neurological Diseases, Hirosaki University School of Medicine, Hirosaki, Japan
,
Tada-Atsu Imalzumi
The Department of Pathological Physiology, Institute of Neurological Diseases, Hirosaki University School of Medicine, Hirosaki, Japan
,
Masayuki Koyama
The Department of Pathological Physiology, Institute of Neurological Diseases, Hirosaki University School of Medicine, Hirosaki, Japan
,
Shigeru Takamatsu
The Department of Pathological Physiology, Institute of Neurological Diseases, Hirosaki University School of Medicine, Hirosaki, Japan
› Author Affiliations
Further Information

Publication History

Received 06 March 1995

Accepted after revision 17 July 1995

Publication Date:
10 July 2018 (online)

Summary

Endothelial cells produce platelet-activating factor (PAF), which is the key process in the interactions between the vascular wall and blood cells. To examine the production of PAF in brain microvasculature we have cultured brain endothelial cells and performed a comparative study with aortic endothelial cells. Fresh porcine brain was homogenized, and microvascular endothelial cells were separated by enzyme digestion. The cells were cultured in medium containing epidermal growth factor and bovine brain extract. Endothelial cells from the aorta of the same animal were cultured in a similar manner. Production of PAF was assessed by ǀ3Hǀacetate incorporation into phospholipids or by radioimmunoassay. Prostacyclin was measured by radioimmunoassay of 6-ketoprostaglandin F. The cells produced 1760 ± 403 and 2892 ± 347 dpm/106 cells (n = 4) of PAF when stimulated with brady- kinin and calcium ionophore A23187, each at 1 μM, respectively. Aortic endothelial cells produced 3911 ± 2006 and 8052 ± 2270 dpm/106 cells (n = 4), respectively, and these values were significantly higher than those in brain endothelial cells (p<0.01, U-test). Prostacyclin production was also higher in aortic cells as compared to brain microvascular endothelial cells. In aortic endothelial cells both Ca ionophore A23187 and bradykinin significantly stimulated PMN adherence whereas in brain microvascular cells only Ca ionophore enhanced the adherence. Brain microvascular endothelial cells produce smaller amount of PAF and prostacyclin as compared to aortic endothelial cells, and this fact may imply that the functional integrity of the brain microvascular endothelium is maintained at a low level.

 
  • References

  • 1 Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium Thromb Res 1977; 11: 323-344
  • 2 Prescott SM, Zimmerman GA, McIntyre TM. Human endothelial cells in culture produce platelet-activating factor (l-alkyl-2-acetyl-sn-glycero-3- phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci USA 1984; 81: 3534-3538
  • 3 Lyberg T, Gaidai KS, Evensen SA, Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983; 53: 85-95
  • 4 Sprengers ED, Kluft C. Plasminogen activator inhibitor. Blood 1987; 69: 381-387
  • 5 Hanahan DJ, Demopoulos CA, Lier J, Pinckard RN. Identification of platelet-activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem 1980; 255: 5514-5516
  • 6 Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990; 259: C697-C708
  • 7 Saito K, Hanahan DJ. Platelet-activating Factor and Diseases. Tokyo; International Medical Publishers: 1989
  • 8 Prescott SM, McIntyre TM, Zimmerman GA. The role of platelet-activating factor in endothelial cells. Thromb Haemost 1990; 64: 99-103
  • 9 McIntyre TM, Zimmerman GA, Satoh K, Prescott SM. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin and adenosine triphosphate. J Clin Invest 1985; 76: 271-280
  • 10 Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, Sanavio F, Bussolino F. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983; 131: 2397-403
  • 11 McIntyre TM, Zimmerman GA, Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986; 83: 2204-2208
  • 12 Zetter BR. The endothelial cells of large and small blood vessels. Diabetes 1981; 30 Suppl (Suppl. 02) 24-28
  • 13 Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Bio-chem Pharmacol 1987; 36: 2701-2711
  • 14 Bowman PD, Betz AL, Ar D, Olinsky JS, Penney JB, Shivers RR, Goldstein GW. Primary culture of capillary endothelium from rat brain. In Vitro 1981; 17: 353-362
  • 15 Voyta JC, Via DP, Butterfield CP, Zetter BR. Identif ication and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoproteins. J Cell Biol 1984; 99: 2034-2040
  • 16 Satoh K, Prescott SM. Culture of mesothelial cells from bovine pericardium and characterization of their arachidonate metabolism. Biochim Biophys Acta 1987; 930: 283-296
  • 17 Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917
  • 18 Mueller HW, O’Flaherty JT, Wykle RL. Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. J Biol Chem 1983; 258: 6213-6218
  • 19 Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children J Clin Invest 1988; 82: 1983-1991
  • 20 Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985; 76: 2235-2246
  • 21 Zimmerman GA, Renzetti AD, Hill HR. Granulocyte adherence in pulmonary and systemic arterial blood samples from patients with adult respiratory distress syndrome. Am Rev Rcspir Dis 1984; 129: 798-804
  • 22 Bowman PD, du Bois M, Dorovini-Zis K, Shivers RR. Microvascular endothelial cells from brain. In: Cell Culture Techniques in Heart and Vessel Research. Piper HM. ed. Berlin; Springer-Verlag: 1990. pp 140-157
  • 23 Dorovini-Zis K, Huynh HK. Ultrastructural localization of factor VUI-re- lated antigen in cultured human brain microvessel endothelial cells. J Histochem Cytochem 1992; 40: 689-696
  • 24 Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988; 82: 2045-2055
  • 25 Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223-234
  • 26 Hirafuji M, Shinoda II. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Br J Pharmacol 1991; 103: 1333-1338
  • 27 Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986; 314: 488-500
  • 28 Lindsberg PJ, Yuc T-L, Freirichs KD, Hallenbcek JM, Feucrstein G. Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke 1990; 21: 1452-1457
  • 29 Whatley RE, Zimmerman GA, McIntyre TM, Prescott SM. Endothelium from diverse sources synthesize platelet-activating factor. Arteriosclerosis 1988; 8: 321-331
  • 30 Lynch JM, Henson PM. The intracellular retention of newly synthesized platelet-activating factor. J Immunol 1986; 137: 2653-2661
  • 31 Lai FM, Shepherd CA, Cervcni P, Wissner A. Hypotensive and vasodila- tory activity of (±)-l-O-oetadeeyl-2-acetyl glyccryl-3-phosphorylcholinc. Life Sci 1983; 32: 1159-1166
  • 32 Dillon PK, Ritter AB, Duran WN. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action. Circ Res 1988; 62: 722-731
  • 33 Yoshimoto S, Ishizaki Y, Sasaki T, Murota S. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991; 22: 378-383
  • 34 Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529-540
  • 35 Miwa M, Sugatani J, Ikemura T, Okamoto Y, Ino M, Saito K, Suzuki Y, Matsumoto M. Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions: contribution of PAF-releasing factor in serum. J Immunol 1992; 148: 872-880